Neurobiomarkers have attracted significant attention over the last ten years. One promising
biomarker is the neurofilament light chain protein (NfL). Since the introduction of …

The recent introduction of new-generation immunoassay methods allows the reliable
quantification of structural brain markers in peripheral matrices. Neurofilament light chain …

Abstract Introduction Neurofilament light chain (NfL) is becoming increasingly notable in
neurological diseases including AD, and it has been suggested as a new peripherical …

Objective: Blood biomarkers of neuronal injury such as neurofilament light (NfL) show
promise to improve diagnosis of neurodegenerative disorders and distinguish …

Frontotemporal dementia (FTD) is one of the most common neurodegenerative diseases,
encompassing a myriad of different, clinically distinct subtypes which all target the …

Recent research advances in young-onset dementia : Current Opinion in Psychiatry Recent
research advances in young-onset dementia : Current Opinion in Psychiatry Log in or …

Objective: People with neuropsychiatric symptoms often experience delay in accurate
diagnosis. Although cerebrospinal fluid neurofilament light (CSF NfL) shows promise in …

Background Lack of early molecular biomarkers in sporadic behavioral variants of
frontotemporal dementia (bvFTD) and its clinical overlap with primary psychiatric disorders …

Background: Distinguishing behavioural variant frontotemporal dementia (bvFTD) from non-
neurodegenerative 'non-progressor'mimics of frontal lobe dysfunction, can be one of the …

Plasma neurofilament light chain (NfL) is a promising biomarker of axonal damage for the
diagnosis of neurodegenerative diseases. Phosphorylated neurofilament heavy chain …